Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05370196 · ClinicalTrials.gov registry record · NA

Synthetic Male Condom Slippage-Breakage Study

A NA study of Sexually Transmitted Diseases and Contraceptive, sponsored by Church & Dwight Company.

Completed
Registry status
NA
Development phase
600
Enrollment target
2
Study locations

NCT05370196 is a NA study of Sexually Transmitted Diseases and Contraceptive that has completed, run by Church & Dwight Company. The registered enrollment target is 600 participants, below the 1,234-participant average among 35 other Sexually Transmitted Diseases trials with a reported enrollment target (51% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05370196, a NA study of Sexually Transmitted Diseases and Contraceptive, has completed, sponsored by Church & Dwight Company.

COMPLETED
Registry status
NA
Development phase
600 participants
Enrollment target
2
Study locations

Study Summary

This is a multi-site, double-blind, crossover, randomized phase II study to evaluate the functional performance of a synthetic male condom as compared to a marketed latex condom.

Interventions

  • DEVICE Test Product
  • DEVICE Control Product

Study Locations (2)

California

  • Essential Access Health - Berkeley
  • Essential Access Health - Los Angeles

Trial Details

FieldValue
Enrollment Target 600 participants
Start Date 2022-06-10
Est. Completion 2023-05-12
Phase NA

Sponsor

Church & Dwight Company

19 total trials

What the Registry Record Tells You About NCT05370196

The ClinicalTrials.gov registry entry for NCT05370196 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 600 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,234-participant average among 35 other Sexually Transmitted Diseases trials with a reported enrollment target (51% lower). The listed sponsor is Church & Dwight Company, which has 19 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Sexually Transmitted Diseases appearing as the primary indexed condition, and to 2 interventions - of which Test Product is the first listed.

NCT05370196 reports 2 study locations spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT05370196 about?

NCT05370196 is a clinical study titled "Synthetic Male Condom Slippage-Breakage Study". This is a multi-site, double-blind, crossover, randomized phase II study to evaluate the functional performance of a synthetic male condom as compared to a marketed latex condom.

What is the current status of trial NCT05370196?

This trial is currently completed. It is a NA study. The enrollment target is 600 participants. The study started on 2022-06-10. Estimated completion is 2023-05-12.

What conditions does trial NCT05370196 study?

This clinical trial studies the following conditions: Sexually Transmitted Diseases, Contraceptive.

What interventions are being tested in trial NCT05370196?

The interventions under investigation include: Test Product (DEVICE), Control Product (DEVICE).

Who is sponsoring clinical trial NCT05370196?

This trial is sponsored by Church & Dwight Company, which has 19 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05370196 being conducted?

This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Sexually Transmitted Diseases

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.